BMAL1 and neoplasm: The inhibitory effects of BMAL1 overexpression were potentiated by co-treatment with melatonin, indicating that melatonin’s anti-tumor effects are consistent with and may amplify the BMAL1-mediated suppression of glycolysis and proliferation.